ELITE PHARMACEUTICALS's ticker is ELTP and the CUSIP is 28659T200. A total of 2 filers reported holding ELITE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $21,000 | +200.0% | 200,807 | +0.4% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 200,000 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -10.0% | 200,000 | 0.0% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 200,000 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +20.0% | 200,000 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | – | 200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 200,000 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 48,778 | $2,000 | 0.00% |